MedTrace Logo

SU JOK THERAPY TO IMPROVE DYSPNEA AND INSOMNIA IN ASTHMA

NCT07746570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2026-08-06

No results posted yet for this study

Summary

Asthma is a long-term lung disease that can make breathing difficult and can also affect sleep. Even with regular medical treatment, many people with asthma continue to experience shortness of breath and insomnia. This study will examine whether Su Jok therapy, a complementary therapy that applies gentle stimulation to specific points on the hands and feet, can help reduce shortness of breath and improve sleep in people with asthma. Adults with asthma who agree to participate will be randomly assigned to one of two groups. One group will receive Su Jok therapy in addition to their usual care, while the other group will receive usual care only. Researchers will compare changes in breathing difficulty and sleep quality between the two groups.

The results of this study may help determine whether Su Jok therapy can be used as a safe and supportive treatment alongside standard asthma care.

Conditions

Interventions

OTHER

su jok therapy

Su Jok therapy was administered by the researcher once daily for five consecutive days in addition to routine asthma care. The intervention involved stimulation of predefined Su Jok correspondence points on the hands according to the study protocol. Each session was performed using standardized procedures to ensure consistency throughout the study.

Sponsors & Collaborators

  • Erzincan Binali Yildirim Universitesi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-02
Primary Completion
2026-07-31
Completion
2026-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07746570 on ClinicalTrials.gov